Literature DB >> 32172896

5-Fluorouracil monodispersed chitosan microspheres: Microfluidic chip fabrication with crosslinking, characterization, drug release and anticancer activity.

Tianxi He1, Wenbin Wang2, Benshou Chen2, Jiu Wang2, Qionglin Liang3, Boshui Chen4.   

Abstract

Different size and morphology monodispersed chitosan (CS) microspheres loaded with the anticancer drug of 5-fluorouracil (5-Fu) were prepared by the microfluidic method assisted by a crosslinking unit with crosslinkers of tripolyphosphate (TPP) and glutaraldehyde (GTA). The sizes, morphologies, drug loading, encapsulation efficiency, drug release and cytotoxicity of 5-Fu loaded CS microspheres were characterized and determined. Results indicated that the CS microspheres were uniform in size distributions. They possessed excellent encapsulation efficiency and drug loading. The TPP-crosslinked CS microspheres had rough surfaces and exhibited faster drug release, whereas the CS microspheres crosslinked with GTA had smooth surfaces and showed slower drug release. Furthermore, 5-Fu-loaded CS microspheres exhibited sustained drug release which well fitted the first-order kinetics model and were pH-responsive in that the drug cumulative release was greater at acidic environments than at neutral conditions. Finally, 5-Fu loaded CS microspheres provided sufficient cytotoxicity and were satisfactory in the cancer cell inhibition.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-(4,5-Dimethylthi-ozol-2-yl) -2,5-diphenyl tetrazolium bromide (MTT, Pubchem CID: 64965); 5-Fluorouracil; 5-fluorouracil (Pubchem CID: 3385); Acetic acid (Pubchem CID:176); Anticancer activity; Chitosan (Pubchem CID: 21896651); Crosslinking; Drug release; Ethanol (Pubchem CID: 702); Glutaraldehyde (GTA, Pubchem CID: 3485); Isopropanol (Pubchem CID: 3776); Microfluidic chip; Monodispersed chitosan microspheres; Sodium dihydngen phosphate anhydrous (Pubchem CID: 23672064); Sodium phosphate dibasic (Pubchem CID: 24203); Tripolyphosphate (TPP, Pubchem CID: 24455)

Year:  2020        PMID: 32172896     DOI: 10.1016/j.carbpol.2020.116094

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

1.  Comparative Drug Release Investigations for Diclofenac Sodium Drug (DS) by Chitosan-Based Grafted and Crosslinked Copolymers.

Authors:  Lalita Chopra; Kamal Kishor Thakur; Jasgurpreet Singh Chohan; Shubham Sharma; R A Ilyas; M R M Asyraf; S Z S Zakaria
Journal:  Materials (Basel)       Date:  2022-03-24       Impact factor: 3.623

2.  Injectable, Anti-Cancer Drug-Eluted Chitosan Microspheres against Osteosarcoma.

Authors:  Jiebing Zhao; Hao Tian; Fusheng Shang; Tao Lv; Dagui Chen; Jianjun Feng
Journal:  J Funct Biomater       Date:  2022-07-10

3.  Vanillin-crosslinked chitosan/ZnO nanocomposites as a drug delivery system for 5-fluorouracil: study on the release behavior via mesoporous ZrO2-Co3O4 nanoparticles modified sensor and antitumor activity.

Authors:  Nehal Salahuddin; Salem Awad; Mona Elfiky
Journal:  RSC Adv       Date:  2022-08-03       Impact factor: 4.036

Review 4.  Application Progress of Modified Chitosan and Its Composite Biomaterials for Bone Tissue Engineering.

Authors:  Yuemeng Zhu; Yidi Zhang; Yanmin Zhou
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

Review 5.  Progress in the application of sustained-release drug microspheres in tissue engineering.

Authors:  Lian Ruan; Mengrong Su; Xinyun Qin; Qingting Ruan; Wen Lang; Minhui Wu; Yujie Chen; Qizhuang Lv
Journal:  Mater Today Bio       Date:  2022-08-13

Review 6.  Droplet Microfluidics for Tumor Drug-Related Studies and Programmable Artificial Cells.

Authors:  Pantelitsa Dimitriou; Jin Li; Giusy Tornillo; Thomas McCloy; David Barrow
Journal:  Glob Chall       Date:  2021-05-07

Review 7.  PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application.

Authors:  Yue Su; Bolun Zhang; Ruowei Sun; Wenfang Liu; Qubo Zhu; Xun Zhang; Rongrong Wang; Chuanpin Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.